Revance Therapeutics, Stock Forecast - Relative Strength Index
RVNCDelisted Stock | USD 3.65 0.00 0.00% |
Revance Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Revance Therapeutics, stock prices and determine the direction of Revance Therapeutics,'s future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Revance Therapeutics,'s historical fundamentals, such as revenue growth or operating cash flow patterns.
Revance |
Previous Relative Strength Index | Relative Strength Index | Trend |
54.56 | 54.56 |
Check Revance Therapeutics, Volatility | Backtest Revance Therapeutics, | Information Ratio |
Revance Therapeutics, Trading Date Momentum
On March 22 2025 Revance Therapeutics, was traded for 3.65 at the closing time. The top price for the day was 3.65 and the lowest listed price was 3.65 . There was no trading activity during the period 0.0. Lack of trading volume on March 22, 2025 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
View Revance Therapeutics, Related Equities
Risk & Return | Correlation |
Revance Therapeutics, Market Strength Events
Market strength indicators help investors to evaluate how Revance Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Revance Therapeutics, shares will generate the highest return on investment. By undertsting and applying Revance Therapeutics, stock market strength indicators, traders can identify Revance Therapeutics, entry and exit signals to maximize returns.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Revance Stock
If you are still planning to invest in Revance Therapeutics, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Revance Therapeutics,'s history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |